These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8061851)

  • 1. Angiotensin-converting enzyme inhibition with spirapril in patients with coronary artery disease.
    Thürmann P; Rietbrock N
    Blood Press Suppl; 1994; 2():73-6. PubMed ID: 8061851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
    Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M
    Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of chronic stable angina pectoris with angiotensin converting enzyme inhibition--a randomized, placebo-controlled, double-blind cross-over study].
    Odenthal HJ; Thürmann P; Wiechmann HW; Josephs W; Lenga P
    Z Kardiol; 1991 Jun; 80(6):392-6. PubMed ID: 1926985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-ischemia effect of enalapril in coronary heart disease. A randomized placebo-controlled double-blind study].
    Rietbrock N; Thürmann P; Kirsten R; Schneider W
    Dtsch Med Wochenschr; 1988 Feb; 113(8):300-2. PubMed ID: 2830091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A Czech and Slovak interventional study of spirapril (the CASSIS study). A randomized, double-blind, multicenter, placebo-controlled study in chronic heart failure].
    Jerie P; Kremer HJ; Uhlír O; Widimský J
    Vnitr Lek; 1997 Jun; 43(6):351-8. PubMed ID: 9601863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placebo-controlled comparison of spirapril at 6, 12 and 24 mg/day in mild to severe essential hypertension.
    Guitard C; Alvisi V; Maibach E; Franck J; Cocco G; Boxho G; Mellein B; Waite R
    Blood Press Suppl; 1994; 2():81-7. PubMed ID: 8061853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
    Cruden NL; Witherow FN; Webb DJ; Fox KA; Newby DE
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of an angiotensin-converting enzyme inhibitor and a K+(ATP) channel opener on warm up angina.
    Edwards RJ; Redwood SR; Lambiase PD; Marber MS
    Eur Heart J; 2005 Mar; 26(6):598-606. PubMed ID: 15618027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicentre multidose study of the efficacy and safety of spirapril in mild-to-moderate essential hypertension. UK Study Group of Spirapril in Hypertension.
    Fairhurst GJ
    Blood Press Suppl; 1994; 2():77-80. PubMed ID: 8061852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
    Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
    Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of zofenopril on myocardial ischemia in post-myocardial infarction patients with preserved left ventricular function: the Survival of Myocardial Infarction Long-term Evaluation (SMILE)-ISCHEMIA study.
    Borghi C; Ambrosioni E;
    Am Heart J; 2007 Mar; 153(3):445.e7-14. PubMed ID: 17307427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of enalapril in normotensive patients with stable effort angina: a double blind, placebo controlled study.
    Lai C; Onnis E; Orani E; Pirisi R; Soro A; Cherchi A
    Drugs Exp Clin Res; 1990; 16(6):299-305. PubMed ID: 2086165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The exercise test with atropine].
    Variola A; Albiero R; Dander B; Buonanno C
    G Ital Cardiol; 1997 Mar; 27(3):255-62. PubMed ID: 9244727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic effects of spirapril and atenolol: results from a randomized, long-term study.
    Hakamäki T; Lehtonen A
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):227-30. PubMed ID: 9208336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spirapril in chronic renal failure.
    Stein G; Sierakowski B; Jansa U; Haufe CC
    Blood Press Suppl; 1994; 2():54-60. PubMed ID: 8061847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of angiotensin-converting enzyme inhibitors on the power spectrum of heart rate variability in post-myocardial infarction patients.
    Kontopoulos AG; Athyros VG; Papageorgiou AA; Skeberis VM; Basayiannis EC; Boudoulas H
    Coron Artery Dis; 1997; 8(8-9):517-24. PubMed ID: 9431480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy of heart failure with spirapril--the open phase of the CASSIS study. Analysis of the 2nd year extension of the CASSIS study].
    Widimský J; Jerie P; Kremer HJ; Uhlír O; Nikodýmová L
    Vnitr Lek; 1997 Jun; 43(6):359-62. PubMed ID: 9601864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.
    McMahon FG; Weinstein SP; Rowe E; Ernst KR; Johnson F; Fujioka K;
    J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Spirapril in the therapy of mild and moderately severe hypertension. A Czech and Slovak multicenter study].
    Widimský J; Lánská V; Hulínský V
    Vnitr Lek; 1995 Nov; 41(11):744-52. PubMed ID: 8553592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of spirapril and captopril on regional blood flow in chronic congestive heart failure: a comparison between a short- and a long-acting angiotensin-converting enzyme inhibitor.
    van den Broek SA; de Graeff PA; Smit AJ; Girbes AR; Journée ; van Gilst WH; Hillege H; van Veldhuisen DJ; Wesseling H; Lie KI
    J Cardiovasc Pharmacol; 1995 Jan; 25(1):105-12. PubMed ID: 7723338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.